Canada Pension Plan Investment Board
JUNO

Canada Pension Plan Investment Board’s Juno Therapeutics, Inc. JUNO Stock Holding History

Canada Pension Plan Investment Board’s Portfolio JUNO Stock Details JUNO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-115,600
Closed -$5.28M – 1334
2017
Q4 		$5.28M Sell
115,600
-31,100
-21% -$1.55M 0.01% 687
2017
Q3 		$6.58M Sell
146,700
-13,900
-9% -$474K 0.01% 604
2017
Q2 		$4.8M Buy
160,600
+66,200
+70% +$1.63M 0.01% 650
2017
Q1 		$2.1M Buy
94,400
+49,700
+111% +$1.07M 0.01% 797
2016
Q4 		$843K Buy
44,700
+23,000
+106% +$563K ﹤0.01% 790
2016
Q3 		$651K Buy
+21,700
New +$675K ﹤0.01% 839

Other funds holding JUNO

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Canada Pension Plan Investment Board's JUNO Position: Q1 2018 in Review

Canada Pension Plan Investment Board sold out of Juno Therapeutics, Inc. (JUNO) in Q1 2018, closing a stake of 115,600 shares — an estimated $5.28M sold.

Canada Pension Plan Investment Board first reported a position in JUNO in Q3 2016 and held it in 6 quarters. The position peaked at $6.58M in Q3 2017. 2 funds tracked by Wall St. Rank hold JUNO as of Q1 2018.

  • Canada Pension Plan Investment Board reported no remaining Juno Therapeutics, Inc. position as of Q1 2018 after selling out during the quarter.
  • Canada Pension Plan Investment Board sold 115,600 Juno Therapeutics, Inc. shares in Q1 2018, an estimated $5.28M.
  • Canada Pension Plan Investment Board first reported a position in Juno Therapeutics, Inc. in Q3 2016 and held it in 6 quarters.
  • Canada Pension Plan Investment Board's Juno Therapeutics, Inc. position peaked at $6.58M in Q3 2017.
  • 2 funds tracked by Wall St. Rank held Juno Therapeutics, Inc. as of Q1 2018.

Based on Canada Pension Plan Investment Board's 13F filing for Q1 2018, filed 14 May 2018.